Abiopharma

🔍 NEVIN DARIUS G (Director)

Company: AstroNova, Inc. (ALOT)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Sold 4,313 shares of Common Stock at $29.0 per share (Direct)
  Date: 2026-08-26 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Sold 30,000 shares of Stock Option (Right to Purchase) at $11.1 per share (Derivative)
  Date: 2026-08-26 | Code: D | Expires: 2035-07-23 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Disposed of pursuant to that certain Agreement and Plan of Merger, dated as of June 16, 2026, by and among AstroNova, Inc. (the "Company"), Orion Merger Parent, Inc. ("Parent"), and Orion MergerCo X, Inc., a wholly owned subsidiary of Parent (as it may be amended from time to time, the "Merger Agreement").
• F2: Stock Option originally granted on July 23, 2025, which became fully vested on January 23, 2026, and was cancelled on the Transaction Date as provided for in the Merger Agreement in exchange for an aggregate cash payment of $537,000, representing an amount equal to the product of: (i) the aggregate number of shares of the Company's common stock, par value $0.05 per share (the "Common Stock") subject to such Stock Option multiplied by (ii) the excess, if any, of $29.00 (the "Merger Consideration") over the per share exercise price under such Stock Option.